“China plans to initially complete the National Rare Disease Registration System by 2020 and conduct more than 50 kinds of 50,000 rare-case registration studies.†In the 12th International Conference on Rare Orphans and Orphans and the 6th China Rare At the Disease Summit Forum, Zhang Yuyang, deputy director of Peking Union Medical College Hospital, said that this study will help to understand the precise clinical phenotype and natural evolution of disease, and lay the foundation for disease intervention research. It is understood that the first batch of rare diseases in the system are divided into 4 categories, including: rare diseases of cardiopulmonary and kidney, endocrine metabolism and rare diseases of the blood system, rare diseases of the nerves and bones and rare diseases of children. At present, there are more than 7,000 rare diseases recognized internationally, accounting for about 10% of human diseases, and about 80% are caused by genetic defects. In 2010, the Chinese Medical Association Genetics Society will refer to a disease with a prevalence of less than 1 in 500,000 or a neonatal morbidity of less than 1 in 10,000 as a rare disease. Since China has a population base of more than 1.3 billion, a special situation in which rare diseases are not uncommon in China has been formed. Dr. Gong Mengchun, Executive Director of the National Rare Disease Registration Research System, hopes that the registration of rare diseases from the clinical perspective will be gradually incorporated into this system. From the perspective of academic and clinical services, a huge turn will be laid nationwide. Consultation, consultation and diagnostic consultation system. Huang Rufang, director of the Center for Rare Disease Development, pointed out that because the number of rare patients is very small, data and research on rare patients are very important in the research and drug development of rare diseases. But for the registration of rare diseases, many patients are not very active and need to be re-educated. “I hope that all patients with rare diseases will actively participate in any scientific and active research and contribute their own data.†"Rare diseases are a major common challenge facing human beings. Global patients are facing huge difficulties. The lack of medical care, slow scientific research, and high global policy barriers are core issues." Huang Rufang pointed out that due to the widespread lack of scientific research, diagnosis The rate is low, the lack of effective treatment and the drugs are often not in the middle of the medical insurance system. Patients with rare diseases must face the dilemma of “disease without medical treatmentâ€, “medical no medicine†and “medicine without protectionâ€. Source: Technology Daily Freestanding Flood Boxwall,Anti-Flood Wall,Blood Wall For Home,Anti Flood Water Barrier Denilco Environmental technology(Suzhou)Co., Ltd. , https://www.wflood.com